Effects of two different low-dose oral contraceptives on plasma homocysteine levels

References

• Blackburn RD, Cunkelman A, Zlidar VM.Oral contraceptives – an update. Popul Rep A 2000;28:1–16, 25–32.
   Google Scholar
• Düsterberg B, Ellman H, Müller U, Rowe E, Mühe B.A three-year clinical investigation into efficacy, cycle control and tolerability of a new low-dose monophasic oral contraceptive containing gestodene. Gynecol Endocrinol 1996;10:33–39.
   PubMed Web of Science ®Google Scholar
• Bannemerschult R, Hanker JP, Wünsch C, Fox P, Albring M, Brill K.A multicenter, uncontrolled clinical investigation of the contraceptive efficacy, cycle control, and safety of a new low dose oral contraceptive containing 20 micrograms EE and 100 micrograms levonorgestrel over six treatment cycles. Contraception 1997;56:285–290.
   PubMed Web of Science ®Google Scholar
• Hite RC, Bannemerschult R, Fox-Kuchenbecker P, Turck R, Brill K.Large observational trial of a new low-dose oral contraceptive containing 20 micrograms ethinylestradiol and 100 micrograms levonorgestrel (Miranova) in Germany. Eur J Contracept Reprod Health Care 1999;4:7–13.
   PubMedGoogle Scholar
• Crook D, Godsland I.Safety evaluation of modern oral contraceptives. Effects on lipoprotein and carbohydrate metabolism. Contraception 1998;57(3):189–201. Contraception 1998;57:420.
   PubMed Web of Science ®Google Scholar
• Kluft C, de Maat MP, Heinemann LA, Spannagl M, Schramm W.Importance of levonorgestrel dose in oral contraceptives for effects on coagulation. Lancet 1999;354:832–833.
   PubMed Web of Science ®Google Scholar
• Zee RY, Mora S, Cheng S, Erlich HA, Lindpaintner K, Rifai N, Buring JE, Ridker PM.Homocysteine, 5,10-methylenetetrahydrofolate reductase 677C > T polymorphism, nutrient intake, and incident cardiovascular disease in 24,968 initially healthy women. Clin Chem 2007;53:845–851.
   PubMed Web of Science ®Google Scholar
• Knopp RH, Broyles FE, Cheung M, Moore K, Marcovina S, Chandler WL.Comparison of the lipoprotein, carbohydrate, and hemostatic effects of phasic oral contraceptives containing desogestrel or levonorgestrel. Contraception 2001;63:1–11.
   PubMed Web of Science ®Google Scholar
• Nehler MR, Taylor LM Jr, Porter JM.Homocysteinemia as a risk factor for atherosclerosis: a review. Cardiovasc Surg 1997;5:559–567.
   PubMedGoogle Scholar
• Boushey CJ, Beresford SA, Omenn GS, Motulsky AG.A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995;274:1049–1057.
   PubMed Web of Science ®Google Scholar
• Auer J, Berent R, Weber T, Lassnig E, Eber B.Homocysteine and cardiovascular risk Wien Med Wochenschr 2001;151:25–28.
   PubMedGoogle Scholar
• Andersson A, Brattström L, Israelsson B, Isaksson A, Hamfelt A, Hultberg B.Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status. Eur J Clin Invest 1992;22:79–87.
   PubMed Web of Science ®Google Scholar
• Wouters MG, Moorrees MT, van der Mooren MJ, Blom HJ, Boers GH, Schellekens LA, Thomas CM, Eskes TK.Plasma homocysteine and menopausal status. Eur J Clin Invest 1995;25:801–805.
   PubMed Web of Science ®Google Scholar
• Tallova J, Tomandl J, Bicikova M, Hill M.Changes of plasma total homocysteine levels during the menstrual cycle. Eur J Clin Invest 1999;29:1041–1044.
   PubMed Web of Science ®Google Scholar
• Brattström L, Israelsson B, Olsson A, Andersson A, Hultberg B.Plasma homocysteine in women on oral oestrogen-containing contraceptives and in men with oestrogen-treated prostatic carcinoma. Scand J Clin Lab Invest 1992;52:283–287.
   PubMed Web of Science ®Google Scholar
• Beaumont V, Malinow MR, Sexton G, Wilson D, Lemort N, Upson B, Beaumont JL.Hyperhomocyst(e)inemia, anti-estrogen antibodies and other risk factors for thrombosis in women on oral contraceptives. Atherosclerosis 1992;94:147–152.
   PubMed Web of Science ®Google Scholar
• LaRosa JC.Androgens and women's health: genetic and epidemiologic aspects of lipid metabolism. Am J Med 1995; 98:22S–26S.
   PubMed Web of Science ®Google Scholar
• Steegers-Theunissen RP, Boers GH, Steegers EA, Trijbels FJ, Thomas CM, Eskes TK.Effects of sub-50 oral contraceptives on homocysteine metabolism: a preliminary study. Contraception 1992;45:129–139.
   PubMed Web of Science ®Google Scholar
• Merki-Feld GS, Imthurn B, Keller PJ.Effects of two oral contraceptives on plasma levels of nitric oxide, homocysteine, and lipid metabolism. Metabolism 2002;51:1216–1221.
   PubMed Web of Science ®Google Scholar
• Green TJ, Houghton LA, Donovan U, Gibson RS, O'Connor DL.Oral contraceptives did not affect biochemical folate indexes and homocysteine concentrations in adolescent females. J Am Diet Assoc 1998;98:49–55.
   PubMedGoogle Scholar
• Seeger H, Petersen G, Schulte-Wintrop E, Teichmann AT, Mueck AO.Effect of two oral contraceptives containing ethinylestradiol and levonorgestrel on serum and urinary surrogate markers of endothelial function. Int J Clin Pharmacol Ther 2002;40:150–157.
   PubMed Web of Science ®Google Scholar
• Hak AE, Bak AA, Lindemans J, Planellas J, Coelingh Bennink HJ, Hofman A, Grobbee DE, Witteman JCThe effect of hormone replacement therapy on serum homocysteine levels in perimenopausal women: a randomized controlled trial. Atherosclerosis 2001;158:437–443.
   PubMed Web of Science ®Google Scholar
• Cagnacci A, Tirelli A, Renzi A, Paoletti AM, Volpe A.Effects of two different oral contraceptives on homocysteine metabolism in women with polycystic ovary syndrome. Contraception 2006;73:348–351.
   PubMed Web of Science ®Google Scholar
• Gul OB, Somunkiran A, Yucel O, Demirci F, Ozdemir IThe effect of ethinyl estradiol-cyproterone acetate treatment on homocysteine levels in women with polycystic ovary syndrome. Arch Gynecol Obstet 2008;277:25–30.
   PubMed Web of Science ®Google Scholar
• Yarali H, Yildirir A, Aybar F, Kabakçi G, Bükülmez O, Akgül E, Oto A.Diastolic dysfunction and increased serum homocysteine concentrations may contribute to increased cardiovascular risk in patients with polycystic ovary syndrome. Fertil Steril 2001;76:511–516.
   PubMed Web of Science ®Google Scholar
• Loverro G, Lorusso F, Mei L, Depalo R, Cormio G, Selvaggi L.The plasma homocysteine levels are increased in polycystic ovary syndrome. Gynecol Obstet Invest 2002;53:157–162.
   PubMed Web of Science ®Google Scholar
• Coulter A, Vessey M, McPherson K, Crossley B.The ability of women to recall their oral contraceptive histories. Contraception. 1986;33:127–137.
   PubMed Web of Science ®Google Scholar